Xiangbing Meng

1.8k total citations
58 papers, 1.3k citations indexed

About

Xiangbing Meng is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiangbing Meng has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 26 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Xiangbing Meng's work include Cancer-related Molecular Pathways (17 papers), Cancer Mechanisms and Therapy (11 papers) and DNA Repair Mechanisms (7 papers). Xiangbing Meng is often cited by papers focused on Cancer-related Molecular Pathways (17 papers), Cancer Mechanisms and Therapy (11 papers) and DNA Repair Mechanisms (7 papers). Xiangbing Meng collaborates with scholars based in United States, China and France. Xiangbing Meng's co-authors include Zhiyuan Shen, Shujie Yang, Kimberly K. Leslie, Kristina W. Thiel, Jingmei Liu, Yuping Zhang, Justin Wray, Xinjun Wang, Huimei Lu and Jac A. Nickoloff and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Xiangbing Meng

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangbing Meng United States 24 912 439 235 225 152 58 1.3k
M. J. Birrer United States 14 947 1.0× 537 1.2× 143 0.6× 337 1.5× 191 1.3× 24 1.5k
Gary K. Yiu United States 13 990 1.1× 379 0.9× 87 0.4× 245 1.1× 252 1.7× 15 1.5k
Yu Zheng China 22 697 0.8× 278 0.6× 84 0.4× 160 0.7× 112 0.7× 48 1.2k
Ying Su China 14 743 0.8× 816 1.9× 91 0.4× 406 1.8× 136 0.9× 24 1.4k
Pierosandro Tagliaferri Italy 17 627 0.7× 308 0.7× 74 0.3× 229 1.0× 147 1.0× 36 983
Huey‐Jen Lin United States 14 707 0.8× 468 1.1× 141 0.6× 248 1.1× 88 0.6× 22 1.1k
Katsuhide Yoshidome Japan 16 610 0.7× 580 1.3× 107 0.5× 271 1.2× 160 1.1× 61 1.3k
Angela Reles Germany 19 610 0.7× 538 1.2× 137 0.6× 387 1.7× 318 2.1× 29 1.5k
Karen M. Hajra United States 7 1.4k 1.6× 679 1.5× 117 0.5× 309 1.4× 120 0.8× 7 1.8k
Clark M. Whitehead United States 17 988 1.1× 380 0.9× 82 0.3× 178 0.8× 167 1.1× 24 1.5k

Countries citing papers authored by Xiangbing Meng

Since Specialization
Citations

This map shows the geographic impact of Xiangbing Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangbing Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangbing Meng more than expected).

Fields of papers citing papers by Xiangbing Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangbing Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangbing Meng. The network helps show where Xiangbing Meng may publish in the future.

Co-authorship network of co-authors of Xiangbing Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangbing Meng. A scholar is included among the top collaborators of Xiangbing Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangbing Meng. Xiangbing Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qianqian, Xiangbing Meng, Muqing Zhang, et al.. (2025). Shaping future sugarcane: Ideal plant architecture and breeding strategies. Molecular Plant. 18(5). 725–728.
2.
Li, Tianyue, et al.. (2024). Abstract 941: Patient-derived model systems of endometrial cancers for disease modeling and drug sensitivity testing. Cancer Research. 84(6_Supplement). 941–941. 1 indexed citations
3.
Naguib, Youssef W., Emad I. Wafa, Sanjib Saha, et al.. (2023). A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. Biomaterials. 296. 122093–122093. 12 indexed citations
4.
Meng, Xiangbing, et al.. (2021). Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations. Frontiers in Medicine. 8. 737951–737951. 19 indexed citations
5.
Bosquet, Jesús González, Shujie Yang, Kristina W. Thiel, et al.. (2017). Role of metadherin in estrogen-regulated gene expression. International Journal of Molecular Medicine. 40(2). 303–310. 3 indexed citations
6.
Ebeid, Kareem, Xiangbing Meng, Kristina W. Thiel, et al.. (2017). Synthetically lethal nanoparticles for treatment of endometrial cancer. Nature Nanotechnology. 13(1). 72–81. 63 indexed citations
7.
Meng, Xiangbing, Shujie Yang, Yuping Zhang, et al.. (2015). Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs. Journal of Biological Chemistry. 290(19). 11853–11864. 20 indexed citations
8.
Yang, Shujie, Xue Xiao, Yichen Jia, et al.. (2014). Epigenetic Modification Restores Functional PR Expression in Endometrial Cancer Cells. Current Pharmaceutical Design. 20(11). 1874–1880. 35 indexed citations
9.
Pineda, Henry Reyes, Kristina W. Thiel, Matthew J. Carlson, et al.. (2014). Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers. Molecular Diagnosis & Therapy. 18(2). 137–151. 34 indexed citations
10.
Meng, Xiangbing, Elizabeth A. Kosmacek, Shujie Yang, et al.. (2012). Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53. Gynecologic Oncology. 128(3). 461–469. 30 indexed citations
11.
Yang, Pingting, Xiangbing Meng, Yi Yang, & Weiguo Xiao. (2012). Inhibition of osteoclast differentiation and matrix metalloproteinase production by CD4+CD25+ T cells in mice. Osteoporosis International. 24(3). 1113–1114. 8 indexed citations
12.
Meng, Xiangbing, Pavla Brachova, Shujie Yang, et al.. (2011). Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment. PLoS ONE. 6(6). e20920–e20920. 46 indexed citations
13.
Meng, Xiangbing, et al.. (2008). Inheritance relation of maize resistant genes among foundation parent huangzaosi and its derivative lines and hybrids. Yumi kexue. 4 indexed citations
14.
Meng, Xiangbing, et al.. (2007). Roles of BCCIP in chromosome stability and cytokinesis. Oncogene. 26(43). 6253–6260. 42 indexed citations
15.
Lü, Hai, Yue Jiang, Xiangbing Meng, Jac A. Nickoloff, & Zhiyuan Shen. (2007). BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage. Nucleic Acids Research. 35(21). 7160–7170. 43 indexed citations
16.
Meng, Xiangbing, Huimei Lu, & Zhiyuan Shen. (2004). BCCIP Functions through p53 to Regulate the Expression of p21Waf1/Cip1. Cell Cycle. 3(11). 1457–1462. 30 indexed citations
17.
Meng, Xiangbing, et al.. (2004). Recovery from DNA Damage-induced G2 Arrest Requires Actin-binding Protein Filamin-A/Actin-binding Protein 280. Journal of Biological Chemistry. 279(7). 6098–6105. 47 indexed citations
18.
Liu, Jingmei, Xiangbing Meng, & Zhiyuan Shen. (2002). Association of human RAD52 protein with transcription factors. Biochemical and Biophysical Research Communications. 297(5). 1191–1196. 17 indexed citations
19.
Tong, Xin, et al.. (2001). Screening of protein interacting with apoptin by yeast two-hybrid from human leucocyte cDNA library. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 28(5). 695–698. 1 indexed citations
20.
Meng, Xiangbing, Yan Dong, & Zhixian Sun. (1999). Mechanism of p53 downstream effectors p21 and Gadd45 in DNA damage surveillance. Science in China Series C Life Sciences. 42(4). 427–434. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. J. Birrer Breakdown of academic impact, for papers by Gary K. Yiu Breakdown of academic impact, for papers by Yu Zheng Breakdown of academic impact, for papers by Ying Su Breakdown of academic impact, for papers by Pierosandro Tagliaferri Breakdown of academic impact, for papers by Huey‐Jen Lin Breakdown of academic impact, for papers by Katsuhide Yoshidome Breakdown of academic impact, for papers by Angela Reles Breakdown of academic impact, for papers by Karen M. Hajra Breakdown of academic impact, for papers by Clark M. Whitehead
Rankless by CCL
2026